Union Science and Technology Minister Dr. Jitendra Singh announced on Thursday, 16 July 2026 the introduction of India's first-ever Engineering Biology undergraduate course, unveiling the landmark initiative at NITI Aayog's roadmap event on 'Building India as a Leading Bioeconomy Powerhouse by 2035.' The course is designed to build an independent, sovereign biotechnology and biology engineering workforce capable of supporting the country's long-term healthcare and economic ambitions.

Context

Speaking at the NITI Aayog event, Dr. Singh drew a sweeping historical parallel: 'Just as the first half of the 21st century was known as the IT century, the second half will be known as the BT — Bio Technology — century.' The Engineering Biology graduation course, he said, would be 'the first of its kind in the country,' preparing a new generation of professionals to work at the intersection of engineering, biology, medicine and emerging technologies.

The announcement was made under the hashtag #DBT, signalling the active role of the Department of Biotechnology — the Ministry of Science and Technology body founded in 1986 — in anchoring the initiative within the broader national bioeconomy strategy.

Policy Backdrop

The move builds on a decade of policy groundwork. The Department of Biotechnology released its National Biotechnology Development Strategy 2015–2020 to position India as a global biotech hub, while NITI Aayog — the policy think tank established in 2015 — published its National Strategy for AI (#AIforAll) in 2018, which outlined integration of artificial intelligence with sectors including biology and healthcare.

The new Engineering Biology course is positioned as the educational cornerstone of this larger ecosystem. Dr. Singh highlighted that future biotechnology would be 'increasingly driven by synthetic biology, AI-enabled biological research and bio-manufacturing' — technologies capable of designing new proteins, developing living-cell-based medicines, clean fuels and sustainable food systems that 'would fundamentally transform healthcare, agriculture and industry over the coming decades.'

The emphasis on a sovereign, independent ecosystem echoes the wider Atmanirbhar Bharat framework that the government has applied to semiconductors, defence and space — and is now extending to biotechnology as a strategic domain.

Stakeholders and Impact

The initiative directly targets biotech students and early-career researchers who would enrol in the new undergraduate programme, equipping them with skills that span synthetic biology, AI-driven research and bio-manufacturing. The healthcare industry, agriculture sector and bio-manufacturing firms are the primary downstream beneficiaries, as the course is explicitly designed to supply a domestic talent pipeline for these sectors.

India's ambition mirrors comparable national strategies pursued by the United States, European Union and China, all of which treat the bioeconomy as strategic infrastructure on a par with defence and digital technology. A domestically trained Engineering Biology cohort would reduce dependence on foreign expertise in areas ranging from cell-based therapeutics to clean energy bio-fuels and sustainable food production.

What's Next

Attention will now turn to the rollout of the Engineering Biology curriculum in select universities and its linkage with DBT-funded laboratories across the country. The release of the full NITI Aayog Bioeconomy 2035 roadmap — and any related budget provisions in the next Union Budget — will be closely watched by the academic community, industry and investors as indicators of the government's financial commitment to the initiative.

If the programme scales as envisioned, India could replicate in biotechnology the self-reliant talent ecosystem it built in information technology after liberalisation — this time with sovereignty in biology as the explicit strategic goal.